Skip to main content
Discover Hidden USA
  • News
  • Health
  • Technology
  • Business
  • Entertainment
  • Sports
  • World
Menu
  • News
  • Health
  • Technology
  • Business
  • Entertainment
  • Sports
  • World
Bryan Johnson, AG1 & Epstein: Longevity Bro Drama Explodes

Bryan Johnson, AG1 & Epstein: Longevity Bro Drama Explodes

February 4, 2026 discoverhiddenusacom Entertainment

The world of “longevity” influencers is facing a turbulent week, marked by public disputes and the resurfacing of connections to convicted sex offender Jeffrey Epstein. The conflict, which has been described as a “rupture” in the online community focused on extending lifespan, involves prominent figures and raises questions about transparency and ethical considerations within the biohacking sphere.

Bryan Johnson and AG1

The initial spark came when Bryan Johnson, a longevity influencer, publicly criticized AG1, a popular nutritional supplement. Johnson claimed a 2024 study showed “no clinical benefit” to the product and labelled the company’s marketing tactics as an “influencer heist.” However, the study in question, conducted over a year prior, actually focused on gut health and safety, finding that AG1 improved levels of two gut probiotic strains and caused no adverse effects.

Did You Know? The clinical trial involving AG1 focused primarily on gut health and safety, observing how well the body tolerated the supplement.

Johnson’s criticism appeared to extend beyond the product itself, potentially targeting fellow longevity podcast hosts Andrew Huberman and Peter Attia, who have benefitted from AG1’s success. AG1 responded by stating the study did not support Johnson’s claims, and Johnson subsequently asserted that the company pays influencers for promotion rather than offering a genuinely valuable product.

The Epstein Files

The controversy surrounding Johnson took a further turn with the release of a new batch of Epstein files by the US Department of Justice. These files revealed communications between Johnson and Epstein’s team, including an attempt to schedule a video call in October 2017, while Johnson was developing his brain tech company Kernel. Johnson later pushed for an in-person meeting, even after Epstein’s 2008 conviction for sex offenses.

Johnson stated he was unaware of Epstein’s conviction at the time of the initial contact. However, records show Johnson’s office reached out to Epstein’s team again in 2018, seemingly to explore fundraising opportunities. Johnson responded to the news by framing the release of the files within a scientific context, describing a neurological response to the information.

Expert Insight: The emergence of these connections highlights the potential for reputational risk among high-profile figures, particularly those operating in the wellness and technology spaces, and underscores the importance of thorough due diligence.

Peter Attia’s Involvement

Peter Attia, also a prominent figure in the longevity space, was also named in the Epstein files, with over 1,700 mentions and hundreds of emails detailing his relationship with Epstein.

Frequently Asked Questions

What initially sparked the conflict?

Bryan Johnson’s criticism of AG1, a nutritional supplement, based on his interpretation of a 2024 study, initiated the dispute.

What did the Epstein files reveal about Bryan Johnson?

The files revealed communications between Johnson and Epstein’s team, including attempts to schedule meetings, even after Epstein’s conviction as a sex offender.

Was Peter Attia also mentioned in the Epstein files?

Yes, Peter Attia was named in the files over 1,700 times, with hundreds of emails detailing his relationship with Epstein.

As these events unfold, it remains to be seen how this will impact the credibility of influencers in the longevity space and the public’s trust in the advice they offer.

Recent Posts

  • A Massive Soccer Village Opens on Brooklyn’s Waterfront: See Photos
  • Cristiano Ronaldo Sends Emphatic Message to His Doubters Before Portugal’s World Cup Opener
  • Toyota’s Wildest Corolla Is Coming To America Packing Race Car DNA
  • A condition affecting 170 million women just got a new name, and doctors say the old one was misleading
  • FDA Approves Sanofi’s Teplizumab for Type 1 Diabetes in Children

Recent Comments

No comments to show.
Discover Hidden USA

Discover Hidden USA helps people discover hidden gems, local businesses, and services across the United States.

Quick Links

  • Privacy Policy
  • About Us
  • Contact
  • Cookie Policy
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 Discover Hidden USA. All rights reserved.

Privacy Policy Terms of Service